22 results
F-1/A
EVAX
Evaxion Biotech A/S
30 Jan 24
Registration statement (foreign) (amended)
3:16pm
care and reducing the health care burden. The goal is to be able to predict which patients will respond to a given therapy. With Proof of Principle … .
The Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act of 2010, or the ACA, includes
F-1
EVAX
Evaxion Biotech A/S
12 Jan 24
Registration statement (foreign)
5:17pm
sooner than expected.
The Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act of 2010, or the ACA … , a medication guide outlining the risks of the product for distribution to patients, a communication plan to health care practitioners, extensive
424B4
esfiw5ts15meoqn dc
5 Nov 21
Prospectus supplement with pricing info
4:47pm
F-1/A
ukfss
3 Nov 21
Registration statement (foreign) (amended)
7:50am
F-1
vby7jtp k6zuj
26 Oct 21
Registration statement (foreign)
7:02am
6-K
EX-99.2
pbn9jquh
25 Oct 21
Evaxion Biotech Announces Clinical Collaboration to Evaluate Lead Product Candidate with KEYTRUDA® (pembrolizumab) in Patients with Melanoma
6:00am
DRS
4l48 6kuyy
25 Jun 21
Draft registration statement
12:00am
20-F
rqkai0j 8f
7 Apr 21
Annual report (foreign)
4:31pm
424B4
b8a2lp
5 Feb 21
Prospectus supplement with pricing info
4:53pm
F-1/A
k8burtw d5
1 Feb 21
Registration statement (foreign) (amended)
4:56pm
F-1/A
i4mcn k2nelhfhjhs
25 Jan 21
Registration statement (foreign) (amended)
7:01am
F-1/A
zx94u95
19 Jan 21
Registration statement (foreign) (amended)
5:05pm
F-1
40xnw3r4nnpdz5
8 Jan 21
Registration statement (foreign)
4:54pm
F-1
EX-10.1
7dlt iduz
8 Jan 21
Registration statement (foreign)
4:54pm
DRS/A
EX-10.1
efwen6dy9h0k m8x
4 Jan 21
Draft registration statement (amended)
12:00am
DRS/A
ic8ty1f3pm
4 Jan 21
Draft registration statement (amended)
12:00am
DRS/A
ynh2 e1qyc
16 Dec 20
Draft registration statement (amended)
12:00am